60 results
Page 2 of 3
20-F/A
EX-4.38
l95bf8w
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
zus0p8z
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.37
f22gt7a 9s
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.17
voenhajvho87lzb453
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
hcwuezfdi2k
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
js857phpq ki
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
2yhi s70qie
5 Mar 15
Current report (foreign)
12:00am
424B2
s9gdh0 zs2pwpu0
13 Jun 14
Prospectus for primary offering
12:00am
F-3
oj2mk00a2g zl7pm14
30 May 14
Shelf registration (foreign)
12:00am
424B5
uw08fc svaf
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
rdxvz 16eq
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
norl oad2333
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
uzgvo4ht63cfttm
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
424B3
3vo684chqn8sbo2l6 0f
8 Aug 13
Prospectus supplement
12:00am